HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

3rd Edition of Global Conference on Gynecology & Women's Health

October 27-29, 2025 | Orlando, Florida, USA

October 27 -29, 2025 | Orlando, Florida, USA

Fetal Alcohol Spectrum Disorder

Fetal Alcohol Spectrum Disorder

Fetal Alcohol Spectrum Disorder (FASD) unravels a narrative of vulnerability and consequences, etched into the lives of individuals who have been exposed to alcohol during gestation. This intricate spectrum encapsulates a range of conditions, from the severe impairments of Fetal Alcohol Syndrome (FAS) to the subtler but equally impactful challenges associated with prenatal alcohol exposure. FASD is a global health concern, transcending geographic boundaries and socioeconomic strata, and highlighting the need for a nuanced understanding of the complex interplay between maternal alcohol consumption and fetal development. The genesis of FASD lies in the teratogenic effects of alcohol, disrupting the delicate dance of embryonic and fetal growth. Central to this disruption is the vulnerability of the developing brain and nervous system. The consequences extend beyond the physical hallmarks often associated with FAS, such as facial dysmorphology, to a labyrinth of neurodevelopmental challenges. Individuals with FASD may grapple with a spectrum of cognitive, behavioral, and adaptive functioning difficulties, making navigation through daily life a perpetual challenge.

Critical to understanding FASD is recognizing that it is not solely determined by the quantity of alcohol consumed, but also by the timing and pattern of exposure. The impacts of even modest alcohol intake during pregnancy can reverberate across a lifetime, influencing not just childhood development but also shaping the trajectory of adolescence and adulthood. The societal implications of FASD extend beyond immediate health concerns, seeping into the realms of education, employment, and social relationships. Preventing FASD involves a multifaceted approach that encompasses public awareness campaigns, education for healthcare professionals, and targeted interventions for individuals at risk. Central to prevention is empowering pregnant individuals with knowledge about the risks of alcohol consumption and providing support for those facing challenges related to substance use. Recognizing the role of societal factors, such as access to healthcare and support services, is crucial in creating an environment that fosters healthier pregnancies and minimizes the incidence of FASD. The diagnostic landscape of FASD has evolved, acknowledging the diversity within the spectrum and tailoring assessments to capture the nuanced manifestations of the disorder. Early identification is pivotal, allowing for timely and targeted interventions that can significantly improve outcomes for affected individuals. The challenge lies not only in refining diagnostic tools but also in fostering a broader understanding of FASD among healthcare providers, educators, and communities.

Committee Members
Speaker at Womens Health Conference - Orfanoudaki Irene

Orfanoudaki Irene

University Hospital of Heraklion, Greece
Speaker at Obstetrics Congress - Marlen Sulamanidze

Marlen Sulamanidze

Total Charm Clinic, Georgia
Speaker at Obstetrics Congress - Mohamed Hosni

Mohamed Hosni

London North West University Hospitals, United Kingdom
Gynec 2025 Speakers
Speaker at Gynecology Conferences - Margot Debrabandere

Margot Debrabandere

Stamford Hospital, United States
Speaker at Gynecology Conferences - Carrie Eutizi

Carrie Eutizi

Arizona Coalition to End Sexual & Domestic Violence, United States
Speaker at Gynecology Conferences - Swati Kumari

Swati Kumari

BronxCare Health System, United States
Speaker at Gynecology Conferences - Cristina Cardenas

Cristina Cardenas

BronxCare Health System, United States
Tags

Submit your abstract Today

Watsapp